MULTI MICRO DOSE Trademark

Trademark Overview

On Tuesday, November 20, 2018, a trademark application was filed for MULTI MICRO DOSE with the United States Patent and Trademark Office. The USPTO has given the MULTI MICRO DOSE trademark a serial number of 88200749. The federal status of this trademark filing is REGISTERED as of Tuesday, January 14, 2020. This trademark is owned by STRATA SKIN SCIENCES, INC.. The MULTI MICRO DOSE trademark is filed in the Medical Instrument Products category with the following description:

Medical device for treating dermatological conditions, namely, laser treatment dosing device which determines optimal patient-specific laser dosages for the treatment of dermatologic conditions
multi micro dose

General Information

Serial Number88200749
Word MarkMULTI MICRO DOSE
Filing DateTuesday, November 20, 2018
Status700 - REGISTERED
Status DateTuesday, January 14, 2020
Registration Number5963571
Registration DateTuesday, January 14, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesMedical device for treating dermatological conditions, namely, laser treatment dosing device which determines optimal patient-specific laser dosages for the treatment of dermatologic conditions

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateSaturday, December 8, 2018
Primary Code010
First Use Anywhere DateTuesday, February 26, 2019
First Use In Commerce DateTuesday, February 26, 2019

Trademark Owner History

Party NameSTRATA SKIN SCIENCES, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressHORSHAM, PA 19044
Party NameSTRATA SKIN SCIENCES, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressHorsham, PA 19044

Trademark Events

Event DateEvent Description
Thursday, October 14, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, October 14, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, October 14, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, October 14, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, October 14, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, January 14, 2020REGISTERED-SUPPLEMENTAL REGISTER
Monday, December 9, 2019LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, December 2, 2019APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Thursday, November 21, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, November 21, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, November 13, 2019ASSIGNED TO LIE
Thursday, November 7, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, September 24, 2019NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Sunday, September 22, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, September 22, 2019NON-FINAL ACTION E-MAILED
Sunday, September 22, 2019USE AMENDMENT ACCEPTED
Sunday, September 22, 2019NON-FINAL ACTION WRITTEN
Tuesday, September 3, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, September 3, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 3, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, August 30, 2019AMENDMENT TO USE PROCESSING COMPLETE
Friday, August 30, 2019USE AMENDMENT FILED
Thursday, August 29, 2019TEAS AMENDMENT OF USE RECEIVED
Friday, March 1, 2019NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Friday, March 1, 2019EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Friday, March 1, 2019COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
Friday, March 1, 2019EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Saturday, February 23, 2019ASSIGNED TO EXAMINER
Saturday, December 8, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, November 23, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

dose micro multi laser conditions treatment device patient optimal specific determines dosages dermatologic